Value-for-money regulation of expensive new medicines: Legitimating decisions through the transformation of uncertainty?
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
No abstract provided
Type: Conference/Paper/Proceeding/Abstract